Stilla Technologies Stilla Technologies Adds dPCR Oncology Menu, End Users as Part of Clinical Pivot Premium The firm is seeing the fruit of a two-year investment in transitioning from a research lab to a clinical focus. Breaking News Trump Signs Executive Order on Matching US Drug Costs to Lower Prices Abroad Genomate Health Raises $2M, Enters US Market With Precision Oncology Clinical Decision Support Tool Hoth Therapeutics Eyeing Human Trials for HT-KIT Antisense Therapy in Early 2026 Nanyang Biologics, Precisya Global Partner to Advance Personalized Medicines for Chronic Diseases FDA Clears Ensoma's IND to Launch Immune Disorder Gene Therapy Trial UTR Therapeutics Submits IND Application for mRNA Destabilizer
